1. Covidien kicks off PAD studies in Europe

    masshightech.com (Aug 8 2011)

    1. Covidien said its Definitive AR anti-restenosis study is enrolling patients at Imelda Hospital in Bonheiden, Belgium. Definitive AR is a pilot study designed to address restenosis, which is the narrowing of a blood vessel in patients with PAD, and will look at the impact of treating a diseased vessel with plaque excision prior to the use of a drug-coated balloon. The study will focus on whether removing calcified plaque will enhance the absorption of drugs delivered by a drug-coated balloon. (Read Full Article)

      Bookmark or Share this article

    Login to comment